Theriva Biologics (TOVX) Earnings Date & Reports

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TOVX is expected to report earnings to fall 14.29% to -5 cents per share on November 17

Theriva Biologics TOVX Stock Earnings Reports

Q3'26

Est.

$-0.06

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.16

Q4'25

Beat

by $1.17

Q3'25

Beat

by $0.68

The last earnings report on August 11 showed earnings per share of -7 cents, missing the estimate of -5 cents. With 122.30K shares outstanding, the current market capitalization sits at 9.94M.

View a ticker or compare two or three

TOVX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for TOVX